Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
01/1999
01/20/1999EP0891344A1 Alpha 1-adrenergic receptor antagonists
01/20/1999EP0891343A1 Inhibitors of farnesyl-protein transferase
01/20/1999EP0891337A1 Inhibitors of farnesyl-protein transferase
01/20/1999EP0891335A1 Inhibitors of farnesyl-protein transferase
01/20/1999EP0891334A1 Inhibitors of farnesyl-protein transferase
01/20/1999EP0693053B1 Urea and amide derivatives and their use in the control of cell membrane potassium channels
01/20/1999CN1205335A Tricyclic diazepine vasopression antagonists
01/20/1999CN1205205A Pyrazolopyridine compound and processes for preparation thereof
01/19/1999US5861425 Indole-ethanamines
01/19/1999US5861404 2,9-disubstituted purin-6-ones
01/19/1999US5861396 Purin-6-one derivatives
01/19/1999US5861394 Use of N-substituted phenothiazines
01/19/1999US5861386 Prevention of loss of bone mass or bone minerals
01/19/1999US5861309 Amino acid sequences encoding it, vectors for its expression in yeast, bacterial, and mammalian cells; research into the characterization of the pharmacology of individual human alpha 1 receptor subtypes
01/19/1999CA2215339C Immunomodulating compositions from bile for the treatment of immune system disorders
01/18/1999CA2237043A1 Response regulator
01/14/1999WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them
01/14/1999WO1999001452A1 Novel cycloalkyl substituted imidazoles
01/14/1999WO1999001451A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
01/14/1999WO1999001164A1 Cloning pigs using donor nuclei from differentiated cells
01/14/1999WO1999001136A1 Novel substituted imidazole compounds
01/14/1999WO1999001131A1 Novel substituted imidazole compounds
01/14/1999WO1999001130A1 Novel substituted imidazole compounds
01/14/1999WO1998039466A3 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
01/14/1999CA2295762A1 Novel cycloalkyl substituted imidazoles
01/14/1999CA2295294A1 Cloning pigs using donor nuclei from differentiated cells
01/14/1999CA2295228A1 Novel substituted imidazole compounds
01/14/1999CA2294524A1 Novel substituted imidazole compounds
01/14/1999CA2294522A1 Novel substituted imidazole compounds
01/14/1999CA2294193A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
01/13/1999EP0889894A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin
01/13/1999EP0889884A1 1,2,4-triazine derivatives for the inhibition of protein glycosylation
01/13/1999EP0889880A1 Eprosartan dihydrate and a process for its production and formulation
01/13/1999EP0889728A2 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
01/13/1999EP0757670B1 Benzamide derivatives as vasopressin antagonists
01/13/1999EP0731787B1 Crystalline, polymorphic form of (s,s,s)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
01/13/1999EP0555327B1 Alkylidene analogs of 1'-aminospiro-[isoquinoline- 4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors in vivo
01/13/1999CN1205009A Pyrazolopyrimidines type compound
01/13/1999CN1204510A Stype using gossypol (and) its derivative as active component and use
01/13/1999CN1041634C Oxytocin antagonist and compound and use thereof
01/12/1999US5859257 Isoxazole compounds as cyclooxygenase inhibitors
01/12/1999US5859229 For inhibition of gene expression of human cyclooxygenase 2 by binding to specific untranslated regions of messenger rna; treatment of premature labor, preeclampsia, endometriosis, rheumatoid arthritis
01/12/1999US5859044 Treating diabetes, hyperglycemia, obesity; increasing content of lean meat in animals
01/12/1999US5859034 Tri-substituted phenyl compounds which have useful pharmaceutical activity
01/12/1999US5859029 Heterocyclic compounds method of preparing them and pharmeutical compositions in which they are present
01/12/1999US5859015 N-heterocyclic piperazinyl and H-heterocyclic piperazinonyl inhibitors of farnesyl-protein transferase
01/12/1999US5859012 Inhibitors of farnesyl-protein transferase
01/12/1999US5859006 Tetracyclic derivatives; process of preparation and use
01/12/1999US5858716 H2CAA71 polynucleotides
01/12/1999US5858360 Mediate embryo-endometrium adhesion; anti-trophinin antibodies for inhibition; trophinin-assisting proteins tastin, bystin, lastin for increasing binding; endometrial adenocarcinoma
01/07/1999WO1999000500A1 Calcium-binding phosphoprotein
01/07/1999WO1999000498A1 Human nk-3 related prostate specific gene-1
01/07/1999WO1999000383A1 Eprosartan monohydrate
01/07/1999WO1998045427A3 Insulin-like growth factor agonist peptides
01/07/1999EP0889129A2 GidA1 polypeptides from Staphylococcus aureus
01/07/1999EP0889127A1 Serine/threonine protein kinase (H-SGK2)
01/07/1999EP0889126A2 YNL075W/HTXFT19 polypeptide
01/07/1999EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase
01/07/1999EP0888385A2 Uses of gdnf and gdnf receptor
01/07/1999EP0888355A1 Heterocyclic compounds and their preparation and use
01/07/1999EP0888341A1 Novel sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives
01/07/1999EP0888340A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
01/07/1999EP0888335A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases
01/07/1999EP0888330A1 Methods of treating or preventing interstitial cystitis
01/07/1999EP0888299A1 Sulphur derivatives with a retroamide bond as endothelin-converting enzyme inhibitors
01/07/1999EP0888298A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
01/07/1999EP0698040A4 Lhrh antagonists
01/07/1999CA2295303A1 Human nk-3 related prostate specific gene-1
01/07/1999CA2295208A1 Calcium-binding phosphoprotein
01/05/1999US5856574 Ortho-subsituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
01/05/1999US5856509 Hypotensive agents
01/05/1999US5856344 Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic aid, and medicament containing them
01/05/1999US5856330 Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
01/03/1999CA2236462A1 Murc
01/02/1999CA2221861A1 Ynl075w/htxft19
01/01/1999CA2236452A1 Gida1
01/01/1999CA2235785A1 Serine/threonine protein kinase (h-sgk2)
12/1998
12/30/1998WO1998058947A1 Dipeptide derivatives as growth hormone secretagogues
12/30/1998WO1998058916A1 NEW β-AMINO AND β-AZIDOCARBOXYLIC ACID DERIVATIVES, THE PRODUCTION THEREOF AND THE USE THEREOF AS ENDOTHELIN RECEPTOR ANTAGONISTS
12/30/1998WO1998058667A1 Use of at least one proteolytic enzyme for treating glomerulonephritis
12/30/1998EP0887416A2 Human AFC1
12/30/1998EP0887415A2 Human RCE1
12/30/1998EP0887406A2 A member of the FRZB family, franzzled
12/30/1998EP0887346A2 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists
12/30/1998EP0887344A1 Quinolines and quinazolines useful in therapy
12/30/1998EP0887081A2 Human serum glucocorticoid regulated kinase, a target for chronic renal disease
12/30/1998EP0760661B1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
12/30/1998CN1203529A 'Gamma'-RAR antagonist ligand or 'alpha'-RAR agonist ligand as apoptosis inhibitor
12/30/1998CN1203228A Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
12/30/1998CN1203102A Medicine for resisting renal failure
12/30/1998CN1203101A Health paster for treating prostatosis and preparing process thereof
12/30/1998CA2294050A1 New .beta.-amino and .beta.-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor antagonists
12/29/1998US5854249 Opioid diarylmethylpiperazines and piperidines
12/29/1998US5853703 Preventing and reversing the formation of advanced glycosylation endproducts
12/27/1998CA2234417A1 Human serum glucocorticoid regulated kinase, a target for chronic renal disease
12/24/1998DE19726253A1 Verwendung von mindestens einem proteolytischen Enzym zur Behandlung von Glomerulonephritis Use of at least a proteolytic enzyme for the treatment of glomerulonephritis
12/24/1998CA2234418A1 Human afc1
12/24/1998CA2234402A1 Human rce1
12/23/1998WO1998057966A1 Novel aryloxy substituted pyrimidine imidazole compounds
12/23/1998WO1998057940A1 Heterocyclic substituted piperidines and uses thereof